Zolmitriptan is a substituted indole-based triptan derivative featuring a 1H-1,2,3-triazole ring fused to a 2-methylindole core, linked via an amide bond to a 4-methoxybenzyl piperazine moiety. The molecule exhibits a methoxy substituent at the indole-5-position and a triazole-piperazine conjugation critical for 5-HT1B/1D receptor selectivity. Structurally, it retains full identity to its parent drug, with no significant degradation or modification. This compound serves as the active pharmaceutical ingredient (API) in the formulation of migraine therapeutics.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| EP | Y0001975 ↗ | 30 MG | EUR 90.00 |
| USP | 1727009 ↗ | 200 mg | USD 292.00 |
CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3
InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1
ULSDMUVEXKOYBU-ZDUSSCGKSA-N